Well we know it wasn’t new data and also unlikely to be a sudden surge in expectation of it despite the many posts urging us to.
As I mentioned the Danish Orphazyme stock experienced some of the same sudden love in the last few weeks, but driven by its ADR listing that for a short moment surged 1000%. The company and analysts were perplexed as to what was driving the stock up and so was Missling back in Feb
So perhaps for now we can classify meme stocks as a US. phenomenon?
In parallel there seems to be more interest in AD stocks and lots of debate or just searching as to which non plaque attack stock could hold potential. This could have that each other’s coattail effect.
Now that we are at last getting closer to the infamous mid-year part of 2021 perhaps some of the $AVXL rise is actually and hopefully based in expectations and increased analyst targets.
Who knows, it is what it is and should not make anyone reassess good due diligence whatever its conclusions as long as you still think it is right.